Minerva Neurosciences Inc. | Key People and Executives
Rémy Luthringer
Executive Chairman & Chief Executive Officer
Jeryl L. Hilleman
Director
William F. Doyle
Lead Independent Director
Hans-Peter Hasler
Independent Director
Thode Fouzia Laghrissi
Independent Director
David J. Kupfer
Independent Director
Jan G. van Heek
Independent Director
Rémy Luthringer
Executive Chairman & Chief Executive Officer
Richard Russell
President
Joseph Reilly
Chief Operating Officer & Senior Vice President
Geoffrey Race
Secretary, Chief Financial & Business Officer
Michael Davidson
Chief Medical Officer
Jay B. Saoud
Senior Vice President, Head-Research & Development
Justine Lalonde
Senior Vice President-Product Strategy
Jeryl L. Hilleman
Director
Frederick W. Ahlholm
Chief Accounting Officer & Senior Vice President
William B. Boni
VP-Investor Relations & Corporate Communications
Devin W. Smith
General Counsel & Senior Vice President
William F. Doyle
Lead Independent Director
Hans-Peter Hasler
Independent Director
Thode Fouzia Laghrissi
Independent Director
David J. Kupfer
Independent Director
Jan G. van Heek
Independent Director
| Address |
1601 Trapelo Road
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.minervaneurosciences.com |
| Updated |
07/08/2019 |
| Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA. |
